Methods: Ninety-one mothers and their adolescents with ADHD (69% boys; M age=12.5, SDage=1.2) were randomly assigned to one of four conditions of full-strength or low-dose/active control (placebo) Cogmed-RM and BPT. Adolescents completed 25 days of Cogmed-RM while mothers participated in five weekly, 90-minute BPT sessions. At pretest and posttest, mothers completed questionnaires assessing cognitive, behavioral, and relationship outcomes, and adolescents completed neuropsychological WM span tasks.
Results: Repeated measures ANOVAs indicated significant main effects of time for most reports of cognitive and behavioral outcomes. For example, mother reports showed improvement from pretest to posttest for: WM, F(1, 87)=73.06, p<.001, ηp2 =.57; ADHD inattentive symptoms, F(1,87)=69.22, p<.001, ηp2 =.44; maternal inconsistent discipline, F(1, 87)=18.94, p<.001, ηp2 =.18; and, oppositional and defiant behaviors F(1, 87)=7.03, p<.01, ηp2 =.08. Additionally, there were significant 2-way interactions of cognitive training condition x time for backward verbal WM span, F(1, 87)=4.67, p<.05, ηp2 =.05, and forward spatial WM span, F(1, 87)=18.66, p<.01, ηp2 =.12, which indicated that the cognitive training treatment group improved more than the placebo group from pretest to posttest.
Conclusion: Our translational research aims include the cost-effective and widespread application of our interventions as a non-pharmacological combination treatment for adolescents with ADHD and their mothers. Overall, results demonstrated that both treatment and placebo groups improved on most outcomes over time. However, some neuropsychological measures of WM spans showed improvement only for the cognitive training treatment group, and perhaps yielded a more objective measure of WM. Completion of separate but concurrent interventions for mothers and their adolescents may influence positive subjective perceptions of change in outcomes, regardless of group condition.